BRAF/MAPK and GSK3 signaling converges to control MITF nuclear export

Area of Science:

• Cellular signaling pathways
• Molecular biology
• Cancer research

Background:

• The MAPK, PI3K, and WNT pathways are crucial for development and are often deregulated in cancer.
• The microphthalmia-associated transcription factor (MITF) is vital for melanocyte development and acts as an oncogene in melanoma.
• Understanding MITF regulation is key to deciphering microenvironmental influences in development and disease.

Purpose of the Study:

• To investigate how key signaling pathways converge to regulate MITF activity.
• To elucidate the mechanism controlling MITF nuclear export.
• To uncover novel regulatory mechanisms of MITF in development and cancer.

Main Methods:

• Investigated the interplay between BRAF/MAPK, PI3K, WNT, and GSK3 signaling pathways.
• Analyzed the phosphorylation status of MITF isoforms.
• Identified a novel hydrophobic export signal regulated by dual phosphorylation.

Main Results:

• BRAF/MAPK and GSK3 signaling converge to control MITF nuclear export.
• Dual phosphorylation of the MITF-M isoform by MAPK and GSK3 primes for nuclear export.
• Nonmelanocyte MITF isoforms are regulated by mTOR, not MAPK signaling.

Conclusions:

• A novel mechanism of MITF regulation integrates key developmental and cancer signaling pathways.
• This regulation controls MITF flux through the import-export cycle, impacting cell fate.
• Findings have significant implications for understanding melanoma progression and stem cell renewal.